15.00--15.10

Objectives
==========

To determine (a) the relationship between primary oesophageal or stomach tumour location, tumour histology and the prevalence of metastatic neck nodes and (b) the effect metastatic neck node detection has on tumour staging.

Patients and methods
====================

Imaging and histological features of 308 patients with oesophageal cancer and 229 patients with stomach cancer at presentation were reviewed. Suspicious neck nodes underwent ultrasound-guided fine needle aspiration for cytology.

Results
=======

Neck node metastases were confirmed in 92/308 (30%) patients with oesophageal cancer, adversely influencing tumour staging in 85/308 (28%) patients. Neck node metastases were confirmed in 46%, 40%, 31%, and 20% of cervical, upper-, mid-, and lower-thoracic tumours, respectively. Neck nodal metastases occurred as commonly with adenocarcinoma as with squamous cell carcinoma of the lower oesophagus (*P*\> 0.05). Neck node metastases were confirmed in 8/229 (3.5%) patients with stomach cancer, adversely influencing staging in 2/229 (0.9%) patients.

Conclusion
==========

Neck node metastases are common in oesophageal cancer at presentation (particularly with more proximally located tumours) and adversely influence tumour staging in the vast majority of patients. Neck node metastases are uncommon in stomach cancer at presentation, are usually associated with extensive intra-abdominal metastatic spread and adversely influence tumour staging in only a small minority of patients.

15.10--15.20

Introduction
============

Oxygen delivery is an important parameter for tissue functionality. Particularly in tumors, low partial pressure of oxygen is a factor for high malignancy and poor response to radiation therapy. Magnetic resonance (MR) imaging of the externally induced blood oxygenation level-dependent (BOLD)-effect by altered oxygen content in the breathing gas might be an interesting approach to quantify oxygen delivery into tumors. But still there are preferential regions and limitations due to organ movement and geometrical distortion.

Methods
=======

For feasibility normal and tumor tissue (gliomas (*n*=5), neck lesions (*n*=4) and prostate cancer (*n*=7)) were investigated using an externally induced BOLD-effect. For oxygen imaging an adapted T2\*-sensitive flow-rephased fast low-angle-shot (FLASH)-sequence was used. To induce changes in blood oxygen-saturation and blood-flow, inhalation gas was alternated between air and 15 l /min carbogen (95% O ~2~, 5% CO ~2~) in four blocks consisting of 30 frames (=5 min) each, starting with air as the baseline condition. Resulting ΔT2\*-maps were calculated and overlaid on anatomical and post-contrast-enhanced T1-w images.

Results
=======

All subjects showed significant (*P*=0.001) ΔT2\* in normal (i.e. gray matter) and in tumor tissue of 4--5%. Signal enhancement was mainly found in the peripheral parts of tumor and its extension tended to correlate this with tumor grade. However, limitations of tumor oxygen imaging using the MR-T2\* technique due to patient compliance, target movement, geometrical distortion and limited field of view were present.

Conclusion
==========

This non-invasive oxygen imaging technique yielded signal enhancement in normal tissue and border regions of tumor. Such enhancement may indicate increased localized oxygen delivery and saturation. Such a monitoring tool may have important implications for radiation therapy planning regimens and overall treatment efficacy.

15.20--15.30

Purpose
=======

To compare dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and diffusion-weighted magnetic resonance imaging (DW-MRI) for noninvasive evaluation of early and late effects of a vascular targeting agent in a rat tumor model.

Materials and methods
=====================

Nine rats with rhabdomyosarcomas in both flanks underwent DCE-MRI and DW-MRI in a 1.5 T MR unit, before and early (1 and 6 h) as well as later (2 and 9 days) after intraperitoneal injection of Combretastatin A-4 phosphate (CA-4-P). Histopathologic correlation was obtained at each time point. To differentiate the influence of perfusion and diffusion, the apparent diffusion coefficient (ADC) was calculated for low (*b*=0, 50, 100 s/mm ^2^; ADC ~low~) and high *b* values (*b*=500, 750, 1000 s/mm ^2^; ADC ~high~). An indicator for the influence of perfusion was arbitrarily defined as the difference between these two values (ADC ~perf~). DCE-MRI was quantified by the volume transfer constant *k* and the initial slope of the contrast-time-curve.

Results
=======

Early after CA-4-P administration, *k*, initial slope as well as ADC ~perf~ decreased significantly (*P*\<0.001), while ADC ~high~ remained essentially unchanged; histology showed still viable tumor tissue. At 2 days the necrotic tumor fraction increased markedly, whereas at 9 days regrowth at the tumor periphery was histologically confirmed. ADC ~high~ increased at 2 days and decreased at 9 days. In turn, *k*, initial slope and ADC ~perf~ increased at 9 days. Changes in ADC ~perf~ correlated with changes in *k*(*R*^2^=0.76) and in initial slope (*R*^2^=0.75).

Conclusion
==========

Both DCE-MRI and DW-MRI allow monitoring of tumor perfusion changes by vascular targeting agents and correlate directly. DW-MRI provides additional information regarding cell viability versus necrosis.

Purpose
=======

To evaluate early effects of a vascular targeting agent on blood flow in a rat rhabdomyosarcoma model using power Doppler ultrasound and subsequent spectral analysis.

Materials and methods
=====================

Rhabdomyosarcomas implanted in both flanks of ten rats were examined by power Doppler ultrasound. Tumor perfusion was studied by visual comparison of the diffuse intratumoral flow and by spectral analysis (resistance index and peak systolic velocity) of the flow in the major feeding vessels penetrating the tumor periphery, before and continuously during the first hour after intraperitoneal injection of a vascular targeting agent \[Combretastatin A-4-Phosphate (OXiGENE, Watertown, MA), 25 mg /kg body weight\]. Follow-up studies were obtained 6 h, 12 h and 2 days after drug administration and correlated with histology.

Results
=======

There was reduction of diffuse flow in 12/20 tumors at 1 h, with complete vascular shutdown in 18/20 tumors at 6 and 12 h. The changes in diffuse flow correlated with the number of intact vessels assessed by histopathology. In 15/20 tumors a major feeding vessel could be visualized. At 1 h, there was signal fragmentation in 10/15 major vessels; at 6 h, the flow was completely absent in 13/15 major vessels. Two days post-injection an increase of flow alongside the occluded major feeding vessels was observed in 12/15 tumors. The resistance index showed no significant post-treatment change; the peak systolic velocity decreased significantly.

Conclusion
==========

Power Doppler demonstrates tumor blood flow changes early after administration of a vascular targeting agent. This technique may be useful for noninvasive treatment monitoring.

15.40--15.50

Introduction
============

Gastro-intestinal stromal tumors (GIST) are rare, with singular genetics. When advanced they are not successfully treatable. Recently multiple experiments with Glivec ^®^ have been performed to genetically prevent this tumoral behavior.

Purpose
=======

To describe the computed tomography (CT) and magnetic resonance (MR) imaging of GIST during treatment with Glivec.

Materials and methods
=====================

Fourteen patients (aged 35--84) underwent CT and MR before and after Glivec. We performed single slice enhanced spiral CT: 60--70 s delay, 1.5 cc /kg of 370 mg Iodine/100 ml contrast medium, 5 mm slice, 0.7 s scan. We used 1 T and 0.3 T (open) magnets, a body coil, FSE T1W, FSE T2W, T2W FATSAT, FastSTIR and ssFSE sequences.

Results
=======

Before therapy metastases have a solid CT pattern, with an inhomogeneous density between 40 and 80 Hounsfield Units (HU); MR confirms the solid lesions inhomogeneously as hyperintense in T2W images. After therapy the metastases are reduced in size and number, modifying the CT and MR patterns: they develop cyst-like densities (average 16 HU), and are not distinguishable from renal cysts. The MR T2 signal increases after therapy, but it is hypointense rather than contiguous with renal or hepatic cysts or cerebrospinal fluid. In disease relapse the CT density is not diagnostic in metastases variations but the MR signal becomes similar to the signal before therapy.

Discussion
==========

The CT pattern after therapy is distinguishable from cysts only because of a critical difference in HU. The cysts are frequently presents in liver: the restaging would be ambiguous. Otherwise the metastases under therapy are easily detectable in MR scans because they have a signal less intense than liver (and kidney) cysts, compared in the same patients, in stable disease, and the same signal as before therapy during relapse.

Conclusion
==========

In evaluating disease-free survival, MR is an important tool and is more user-friendly than CT.

15.50--16.00

Aim
===

To assess the role of integrated fluorine-18-labelled fluorodeoxyglucose (^18^F-FDG) positron emission tomography (PET)/computed tomography (CT) and thin collimation multi-detector CT imaging in pancreatic and ampullary tumours.

Methods and results
===================

Between 2002 and 2004, 51 patients (43 with pancreatic and eight with ampullary cancers) underwent staging with ^18^F-FDG PET/CT and multi-detector CT scans (pancreatic protocol pre and two phase contrast-enhanced examinations). Thirty patients had disease localised to primary tumour and 20 patients had evidence of lymphatic spread and/or liver metastases. Multi-detector CT and ^18^F-FDG PET/CT correctly identified all primary lesions. Multi-detector CT was more accurate in distinguishing resectable (T1--3) and locally advanced (T4) primary tumours compared to ^18^F-FDG PET/CT. In patients with Stage IIB--IV ^18^F-FDG PET/CT up-staged 15% and down-staged 10% and identified co-existing pathology (three patients with dysplastic colonic polyps). ^18^F-FDG PET/CT identified one false-positive lung lesion (granuloma) and one false-negative liver metastases.

Conclusion
==========

^18^F-FDG PET/CT and multi-detector CT are complementary imaging modalities for staging exocrine pancreatic and ampullary tumours. The high resolution of multi-detector CT allows accurate local staging (Stage I--IIA). ^18^F-FDG PET/CT impacts on Stage IIB--IV disease and helps identify co-existing pathology.

16.00--16.10

Purpose
=======

The aim of this study was to evaluate the different computed tomography (CT) parameters, characterizing tissue perfusion by contrast medium in rectal carcinomas, and to define their relation with angiogenetic activity.

Materials and methods
=====================

Thirty-seven patients with rectal cancer (24 of them before and after neo-adjuvant radio- and chemotherapy) were studied by dynamic CT (16 slices light-speed G.E., scanned every second for 150 s, after i.v. 2 ml /s injection of 40 ml of 350 mg /dl iodine contrast medium): semi-automatic calculations of time to peak (TTP), positive enhancement integral (PEI), maximum slope of increase (MSI), maximum slope of decrease (MSD), blood flow (BF), blood volume (BV), mean transit time (MTT) and permeability surface (PS) were performed. The distribution of values in normal and neoplastic walls, their variation after therapies and their relations with pathological vessel density (MVD) were evaluated.

Results
=======

BF, TTP and PS were higher in tumor than in normal wall in 68, 76 and 100% of patients, respectively; PS was \>20 ml /min per 100 g in 100% of patients. PS decreased in 78% of patients submitted to neo-adjuvant radio-chemotherapy. A significant correlation between TTP and MVD was found (*R*=0.832).

Conclusions
===========

CT perfusion could be reliable in the study of the neo-angiogenetic process, characterized by an increase in vessel numbers, vascular permeability and flow into extravascular spaces, to a greater extent than the pathological MVD count: imaging will be used in monitoring targeted therapies, in the assessment of different angiogenetic patterns in tumors and in the selection of patients eligible to be treated by antiangiogenic therapy.

16.10--16.20

Purpose
=======

Pseudomyxoma peritonei (PP) is a rare clinical entity in which collections of gelatinous material accumulate within the peritoneal cavity. The aim of our retrospective study was to describe the computed tomography (CT) findings in 19 patients referred to our hospital for surgical cytoreduction.

Methods
=======

The CT examinations were performed between September 1996 and October 2003. Abdominal and pelvic CT images were reviewed by two observers using both the hard copies (*n*=12) and Picture Archiving and Communications System (PACS)-stored images (*n*=7). There were nine women and ten men with a mean age of 55 years (range 22--76 years).

Results
=======

PP was identified as low-density mucinous collections with means of 24 and 26 HU on native and contrast-enhanced images, respectively. Small calcifications (*n*=6), septae (*n*=6), areas of high attenuation (*n*=8), and extension to the pleural cavity (*n*=2) and to the hernial orifices (*n*=2) were seen in medium to large volume of disease (*n*=13). Calcification (*n*=1) and a high attenuation area (*n*=1) but no septations were seen in six patients with small pseudomyxoma collections.

16.20--16.30

Purpose
=======

To compare magnetic resonance imaging (MRI) and magnetic resonance cholangiopancreatography (MRCP) with surgical and histopathologic findings in the evaluation and staging of hilar cholangiocarcinomas (Klatskin's tumor).

Materials and methods
=====================

Fifteen patients with hilar cholangiocarcinoma were examined with MRI and MRCP. The diagnosis of hilar cholangiocarcinomas was confirmed by surgical exploration. Two radiologists retrospectively evaluated MR images to assess tumor growth characteristics, tumor signal intensity features, tumor enhancement pattern, extent of bile duct stenosis, liver parenchymal and vascular involvement, presence of liver atrophy and lymph node enlargement. Furthermore the accuracy of MRI/MRCP in defining tumor resectability was determined, compared to surgical and histopathologic findings.

Results
=======

Tumor growth characteristics were judged as mass-forming in 12 /15 (80%) patients and periductal infiltration morphology in 3 /15 (20%) patients. On T1-weighted images, 12 /15 (80%) lesions were hypointense to adjacent liver parenchyma, and 3 /15 lesions were isointense. On T2-weighted images, 13 /15 (87%) cholangiocarcinomas appeared hyperintense compared to adjacent liver parenchyma, and 2 /15 (13%) appeared isointense. All cholangiocarcinomas were hypovascular compared to adjacent liver parenchyma; 14 /15 (93%) lesions showed a delayed enhancement and 1 /15 patients showed delayed wash out. The extent of bile duct stenosis was correctly predicted by MRI/MRCP in 13 /15 (87%) patients. MRI correctly predicted vascular involvement in 11 /15 (73%) patients, liver involvement in 12 /15 (80%) patients, and liver atrophy in 6 /15 (40%) patients. The overall accuracy of MR for predicting resectability was 91%.

Conclusion
==========

The combination of MRI and MRCP is a reliable diagnostic method for staging hilar cholangiocarcinomas, and is helpful in treatment planning.
